Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
Chemmedchem|March 8, 2023
Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT-774312Hamed Aissaoui, Martin Holdener, Carmela Gnerre, et al.The Journal of Biological Chemistry|April 21, 2005
X-ray structure of plasmepsin II complexed with a potent achiral inhibitorLars Prade, Andrew F Jones, Christoph Boss, et al.Dalton Transactions (Cambridge, England : 2003)|July 29, 2025
Immobilization of Keggin-type polyoxometalates in cyclodextrin-based polymers for oxidation catalysisSana Aniba, Nathalie Leclerc, Clément Falaise, et al.Bioorganic & Medicinal Chemistry Letters|October 11, 2008
N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonistsHamed Aissaoui, Ralf Koberstein, Cornelia Zumbrunn, et al.Chimia|October 27, 2017
The Screening Compound Collection: A Key Asset for Drug DiscoveryChristoph Boss, Julien Hazemann, Thierry Kimmerlin, et al.Frontiers in Chemistry|October 16, 2018
A Multifunctional Dual-Luminescent Polyoxometalate@Metal-Organic Framework EuW10@UiO-67 Composite as Chemical Probe and Temperature SensorWilliam Salomon, Anne Dolbecq, Catherine Roch-Marchal, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trialBarbara L Brody, Anne-Catherine Roch-Levecq, Ronald G Thomas, et al.Journal of the American Geriatrics Society|October 14, 2006
Age-related macular degeneration: self-management and reduction of depressive symptoms in a randomized, controlled studyBarbara L Brody, Anne-Catherine Roch-Levecq, Robert M Kaplan, et al.Chemmedchem|March 9, 2023
CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol MetabolitesAlexander Treiber, Hamed Aissaoui, Stéphane Delahaye, et al.Chemmedchem|November 20, 2023
Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective InhibitorsOlivier Corminboeuf, Stefan Diethelm, Cornelia Zumbrunn, et al.Pageof 9